EICHOR
● Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Condition: SLE · SLE (Systemic Lupus) · Sponsor: Cullinan Therapeutics Inc.
About this study
Phase 1b, open-label study of CLN-978 administered subcutaneously in patients with Moderate to Severe Systemic Lupus Erythematosus (SLE).
This description comes directly from the study's public registry record.
Talk to the study team
Meagan Sardinha · +1 617 410 4650 · ClinOps@cullinantx.com
Always discuss trial participation with your own doctor first.
Locations (20)
| AARA Clinical Research | Avondale, Arizona, United States | Recruiting |
| AARA Clinical Research | Tucson, Arizona, United States | Recruiting |
| Omega Research Group | Orlando, Florida, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| Columbia University Medical Center | New York, New York, United States | Recruiting |
| University of Rochester Medical Center | Rochester, New York, United States | Recruiting |
| Regional One Health | Memphis, Tennessee, United States | Recruiting |
| Stryde Research | Plano, Texas, United States | Recruiting |
| Tranquil Clinical Research | Webster, Texas, United States | Recruiting |
| Intermountain Health | Salt Lake City, Utah, United States | Recruiting |
| Royal Melbourne Hospital | Parkville, Australia | Recruiting |
| Osteoporosis Solutions | Victoria Park, Australia | Recruiting |
+ 8 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06613360